Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323356 | SCV001514268 | uncertain significance | Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | 2021-08-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035098 | SCV005004530 | uncertain significance | not specified | 2024-01-19 | criteria provided, single submitter | clinical testing | The c.412A>G (p.M138V) alteration is located in exon 1 (coding exon 1) of the PIGM gene. This alteration results from a A to G substitution at nucleotide position 412, causing the methionine (M) at amino acid position 138 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |